Identity
Alias Bourneville disease; Epiloia Inheritance Frequency: 1/6000-1/10000 birth. First genetic cause of epilepsy associated with mental retardation = epiloia. 2/3 of cases are sporadic, 1/3 are inherited. Genetic heterogeneity: two genes, TSC1 and TSC2, account for the majority of cases. Somatic mosaicism has been reported in association with a milder form of the disease. Germinal mosaicism has been described and must be taken into account for genetic counselling. Autosomal dominant with almost complete penetrance but variable expressivity.
Clinics
Note Disability in TSC patients most often results from the involvement of brain. Two types of lesions are static (hamartias); cortical tubers, and subcortical heterotopic nodules, whereas subependymal nodules are often progressive (hamartoma), hence the term subependymal giant cell astrocytoma.
Phenotype and clinics
The definition of the tuberous sclerosis complex requires either two major features or one major feature plus two minor features. 
Neoplastic risk
Renal angiomyolipomas, often multiple and bilateral, (75% of children withTSC). occasionnally (< 2-3%), turn into renal carcinomaonly later in life. Cardiac rhabdomyomas, often congenital, tend to regress in infancy, remain identical in same size through out childhood and can then either again regress or progress (girls) in adolescence. Brain tumors, (incidence 5-14%), are mostly (>90%) subependymal giant cell astrocytomas, or ependymomas. Hamartomas also occur in liver, spleen, and various tissues. Pulmonary lymphangiomyomatosis is a destructive lung disease characterized by a diffuse hamartomatous proliferation of smooth muscle cells in lungs.
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Cytogenetics
Inborn conditions
Increased frequency of premature centromere disjonction (PCD) in cultured fibroblasts, especially for chromosome 3.
Cytogenetics of cancer
No special feature.
Genes involved and proteins
Note
Two genes are involved, TSC1 and TSC2. The patients with TSC1 mutations would have a milder form of the disease, compared to those with TSC2 mutations.
TSC1
Location 9q34 Note Accounts for about 50% of TSC patients. DNA/RNA Description : 23 exons. Protein Note: Tumor suppressor. Description: Hamartin and tuberin cohybridize in vivo. Hamartin is a growth inhibitory protein, affecting cell proliferation via deregulation of G1 phase, possibly by regulating cellular adhesion through ezrin-radixinmoiesin family proteins and the small GTP-binding protein RHO.
TSC2
Location 16p13 Note Accounts for about 50% of TSC patients. DNA/RNA Description: 41 exons. Protein Note: Tumor suppressor. Fonctions: as a GTPase activating protein which activates the Ras-related family of small GTP-binding proteins such as Rap1 and Rab5. Inhibits the G1/S transition and promotes entry to the G0 phase. The Eker rat, a naturally occuring animal model of TSC, has an autosomal dominant trait of renal cell carcinoma caused by a germline mutation in the rat TSC2 gene.
Mutations
Germinal: Most TSC1 and TSC2 mutations are truncating mutations. Both large deletions and missense mutations are not uncommon at TSC2 locus, whereas most TSC1 mutations are small truncating lesions. Somatic: Loss of heterozygosity has been described in some tumor types, such as angiomyolipomas, giant cell astrocytomas, or rhabdomyomas, but is rare in cortical tubers.
